An undiscovered pearl -- A survey of Soho-Yiming by Yi Chengdong, deputy director of Shanghai Food and Drug Administration

On the morning of January 5th, Yi Chengdong, Deputy Director of Shanghai Food and Drug Administration, Li Ping, Director of Pharmaceuticals and Cosmetics Supervision Division, and Li Jianping, Minister of GMP Certification Center, visited Shanghai Soho-Yiming Pharmaceutical Co., Ltd. to conduct research and guide work. The company's general manager Zhou Yiming, deputy general managers Zhou Dawei, Xu Qiangqiang, Zhu Liang, Cui Qi and leaders of related departments welcomed the deputy director Yi and his party.
Deputy Director Yi spoke highly of the outstanding.Mr Yi highly evaluated Soho-Yiming outstanding contribution in the field of polypeptides and described him as an undiscovered pearl. He encouraged all employees of Soho-Yiming to work tirelessly, stick to their ideals, and move forward bravely. He believes that everyone will make small molecule peptides bigger and stronger, being global, and become the pride of Chinese peptide drugs. Deputy Director Yi also praised General Manager Zhou Yiming for his outstanding contributions to the peptide business, and said with a smile: "Although we have never met, I have heard of your reputation.Deputy Director Yi also introduced the Shanghai Municipal Government’s positioning of the bio-industry: it must have its own characteristics and be able to form its own advantages. These were originally highly consistent with Soho-Yiming's industrial positioning and development plan, so everyone was greatly encouraged and full of confidence in the future.

At the meeting, General Manager Zhou Yiming gave an introduction on corporate development, quality management, R&D innovation, and international certification. After listening to the report, Deputy Director Yi fully recognized the company's strategic development policy based on scientific research and aimed at international certification, and fully affirmed the company's variety and structure.Deputy Director Yi put forward four wishes and requirements to everyone: 1. Strength GMP management and control the quality of products from the source; 2. Peptide drugs are highly active drugs, and prevention of cross-contamination is the top priority; 3. Do a good job, in-depth, and meticulously do the annual quality review work, which is very important for the quality supervision of enterprises; 4. Standardized development, standardization promotes development, development promotes standardization, so as to further enhance the company's domestic and foreign reputation and makes this "unexplored pearl" show its true value.Deputy Director Yi also learned in detail about the industrial situation and future development of Soho-Yiming's parent company Ankebio, and encouraged everyone to develop faster and better in the big family of Ankebio Group.